Therefore, our results, together with previously published studies, suggest that ASF1B acts as a cancer-promoting factor in the development of multiple cancers, providing a basis for the use of ASF1B as a therapeutic target for LGG or other cancers. The gene discussed is ASF1B; the disease is cancer.